Henry Schein Announces Participation in Investor Conferences in June

Rhea-AI Summary

Henry Schein, the largest provider of healthcare solutions for dental and medical practitioners, announced its participation in two upcoming investor conferences in June 2022. The events include the Stifel 2022 Annual Dental & Veterinary Conference on June 1 and the Jefferies 2022 Healthcare Conference on June 9. Live webcasts of the presentations will be available on Henry Schein's investor relations website. The company highlights its extensive global network, serving over 1 million customers with more than 300 solutions aimed at enhancing operational success and clinical outcomes.

Positive

• Participation in two significant investor conferences enhances visibility among investors and analysts.
• Strong global presence with nearly 22,000 team members supporting over 1 million customers.

Negative

• None.

MELVILLE, N.Y.--(BUSINESS WIRE)-- Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in June:

• Stifel 2022 Annual Dental & Veterinary Conference on June 1, 2022, at 10:55 a.m. Eastern time.
• Jefferies 2022 Healthcare Conference on June 9, 2022, at 1:30 p.m. Eastern time.

Henry Schein’s presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be available on the Henry Schein website following the presentations.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With nearly 22,000 TSMs Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries and territories. The Company's sales reached $12.4 billion in 2021, and have grown at a compound annual rate of approximately 12.5 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, and @HenrySchein on Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220517006302/en/

Investors

Ronald N. South

Senior Vice President and Chief Financial Officer

ronald.south@henryschein.com

(631) 845-2802

Graham Stanley

Vice President, Investor Relations and Strategic Financial Project Officer

graham.stanley@henryschein.com

(631) 843-5963

Media

Ann Marie Gothard

Vice President, Global Corporate Media Relations

annmarie.gothard@henryschein.com

(631) 390-8169

Source: Henry Schein, Inc.

FAQ

What investor conferences is HSIC participating in June 2022?

HSIC will present at the Stifel 2022 Annual Dental & Veterinary Conference on June 1 and the Jefferies 2022 Healthcare Conference on June 9, 2022.

How can I listen to HSIC's conference presentations?

You can listen to HSIC's presentations via live webcast by visiting their investor relations website.

What is the focus of Henry Schein's business?

Henry Schein focuses on providing healthcare solutions for dental and medical practitioners globally.

What is the significance of HSIC's global network?

HSIC's global network of nearly 22,000 team members supports operational success and clinical outcomes for over 1 million customers.